Wird geladen...
Engineering the AAV Capsid to Evade Immune Responses
Gene therapy is progressively emerging as a promising and powerful therapeutic modality, and adeno-associated virus (AAV) is a major delivery vehicle for such therapies. Among the most significant challenges that limit AAV’s utility, however, is the immune response it elicits. Antibodies elicited by...
Gespeichert in:
| Veröffentlicht in: | Curr Opin Biotechnol |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7117822/ https://ncbi.nlm.nih.gov/pubmed/30807882 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.copbio.2019.01.002 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|